Similarly, high basal expression of TG2 in breast cancer cells (MDA-231, MCF7/RT) though promotes certain stem cell properties (CD44high/CD24low/- phenotype, ability to form mammospheres, and self-renewal ability) but failed to support their terminal differentiation. Here, TGM2 is linked to breast carcinoma.